Cardinal Health, Inc. Stock 12‑Month Price Target Raised to $277.87, Implies 11% Upside

What happened

According to estimates from 15 analysts, Cardinal Health's average price target rose from $276.47 to $277.87 per share, with forecasts ranging from $260 to $295. Based on the Oct. 29 closing price, the new target implies about 11% potential upside.

Confirmed

Global impact / market context

A higher average price target means analysts collectively expect Cardinal Health shares to be worth more than before. This influences investor positioning because a higher expected return can encourage buying, though the target is an estimate and actual results can differ.

Analyst inference

The consensus rating stays at Buy across 21 analysts, split into 16 Buys, 5 Holds and 0 Sells. That suggests most covering analysts remain positive on the stock, while the $260 to $295 target range shows disagreement about fair value.

Analyst inference

What to watch

1. Watch whether the average price target moves again, since it was just raised from $276.47 to $277.87, implying roughly 11% upside from the Oct. 29 closing price. Confirmed
2. Track future analyst rating changes, because the current mix of 16 Buys, 5 Holds and 0 Sells could shift if analysts revise their views on Cardinal Health and adjust recommendations. Proposed
3. Monitor how the share price compares with the $260 to $295 forecast range, since falling below the low end or rising above the high end would signal expectations diverging from analyst estimates. Analyst inference

Evidence

• Original source link unavailable